Showing results (1631-1640 of 1,717) with videos related to
Sort By:
Pageof 172
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.ESMO Open|August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedgeM Bono, D Fanale, L Incorvaia, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?D Santini, B Vincenzi, R Addeo, et al.Autophagy|February 22, 2015
SIRT5 regulation of ammonia-induced autophagy and mitophagyLucia Polletta, Enza Vernucci, Ilaria Carnevale, et al.International Journal of Cardiology|July 11, 2015
Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosisEleonora Foglio, Giovanni Puddighinu, Pasquale Fasanaro, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 13, 2018
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO TrialPiet Geusens, Fernando Marin, David L Kendler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)C Gridelli, F Perrone, S Palmeri, et al.Lancet (London, England)|November 14, 2017
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trialDavid L Kendler, Fernando Marin, Cristiano A F Zerbini, et al.Proceedings of the National Academy of Sciences of the United States of America|December 13, 2022
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant <i>Acinetobacter baumannii</i>Thomas A Russo, Timothy C Umland, Xiaoyi Deng, et al.Plos One|June 23, 2012
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic studyJan Marc Orenstein, Stanford T Shulman, Linda M Fox, et al.Pageof 172